A Comprehensive Study on Technological Advancements in Treatment and Prognosis of Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is an aggressive blood malignancy that targets myeloid cells, also known as Acute Myelogenous Leukemia, and arises from a genetic mutation that initiates uncontrolled growth in a group of cells derived from a common precursor. Advances in understanding the abnormal changes in biological systems leading to AML are swiftly enhancing both treatment strategies and prognostic outcomes. Given the diverse nature of AML, personalized therapeutic approaches are crucial for each patient. This technology overview delves into recent AML diagnosis and treatment breakthroughs, incorporating Semantic Web technology, Artificial Intelligence, and Digital Image processing. These significant developments have the potential to improve patient outcomes, refine therapy methods, and ultimately contribute to continuing efforts to comprehend better and combat this difficult hematologic malignancy.